Literature DB >> 11943130

Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus.

Sadi Kaplan1, Sinan Ekici, Riza Doğan, Metin Demircin, Haluk Ozen, Ilhan Paşaoğlu.   

Abstract

BACKGROUND: The successful excision of a renal cell carcinoma (RCC) invading the inferior vena cava (IVC) remains a technical intraoperative challenge and requires a careful preoperative surgical management planning. Although a radical operation remains the mainstay of the therapy for RCC, the optimal management of the patients with RCC causing IVC tumor thrombus remains unresolved. In this study, we reviewed our experience in this group of patients and herein report the results.
METHODS: Between July 1990 and August 1998, 11 patients with RCC with IVC tumor thrombus underwent surgical treatment. The mean patient age was 54.2 years and the male to female ratio was 1.75. The cephalad extension of the tumor was suprarenal in all cases, being infrahepatic in 6 patients, intrahepatic in 2, and suprahepatic with right atrial extension in 3 patients. All tumors were resected via inferior vena cava isolation and, when necessary, extended hepatic mobilization and Pringle maneuver, with primary or patch closure of vena cavotomy. Cardiopulmonary bypass (CPB) and deep hypothermic circulatory arrest (DHCA) were used in 3 patients.
RESULTS: The mortality rate was 9.1% (1 patient was lost on the 11th postoperative day). Complications occurred in 3 patients. The remaining 10 patients (90.9%) could be successfully discharged from hospital. Two of them were lost during follow-up because of tumor progression at the 43rd and 54th postoperative months. The 10-year Kaplan-Meier survival estimate was 71.4%, with a mean follow-up of 4.6 years. The presence of lymph node metastases and perinephric spread seemed to possess an adverse effect on the survival. Although the groups included small numbers of patients, there was no significant difference in survival in regard to the different levels of tumor thrombus extension into the vena cava.
CONCLUSIONS: Surgical treatment is the preferred approach to patients with RCC and IVC tumor thrombi as it provides markedly better results when compared with the other therapeutical modalities. We believe that complete surgical excision of the tumor and the resulting thrombus with appropriate preoperative staging and a well-planned surgical approach, using CPB and DHCA when necessary, provide an acceptable long-term survival with a good quality of life expectation.

Entities:  

Mesh:

Year:  2002        PMID: 11943130     DOI: 10.1016/s0002-9610(02)00782-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  17 in total

Review 1.  Imaging of advanced renal cell carcinoma.

Authors:  Ullrich G Mueller-Lisse; Ulrike L Mueller-Lisse
Journal:  World J Urol       Date:  2010-05-11       Impact factor: 4.226

2.  Resection and reconstruction of the inferior vena cava for neoplasms.

Authors:  Nikola Nikolov Vladov; Vassil Ivanov Mihaylov; Nikolai Vassilev Belev; Ventzislav Metodiev Mutafchiiski; Ivelin Rumenov Takorov; Sergei Kirilov Sergeev; Evelina Hristova Odisseeva
Journal:  World J Gastrointest Surg       Date:  2012-04-27

3.  Challenging surgery for retroperitoneal tumors and liver transplant surgeons.

Authors:  Murat Akyol
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

4.  Renal pelvic urothelial carcinoma with vena caval thrombus mimicking renal cell carcinoma.

Authors:  Richilda Red Diaz; Jong Kyou Kwon; Joo Yong Lee; Ji Hae Nahm; Kang Su Cho; Won Sik Ham; Nam Hoon Cho; Young Deuk Choi
Journal:  Korean J Urol       Date:  2014-09-05

Review 5.  Staging of renal cell carcinoma.

Authors:  Ullrich G Mueller-Lisse; Ulrike L Mueller-Lisse; Thomas Meindl; Eva Coppenrath; Christoph Degenhart; Anno Graser; Michael Scherr; Maximilian F Reiser
Journal:  Eur Radiol       Date:  2007-02-22       Impact factor: 5.315

6.  [Renal carcinoma with invasion of the suprahepatic vena cava (Staehler stage III and IV): surgical treatment and results].

Authors:  J Roigas; A Wille; K Winter; S Deger; I Türk; R I Rückert; J Bohm; D Schnorr
Journal:  Urologe A       Date:  2003-01-30       Impact factor: 0.639

7.  IVC Thrombectomy in Renal Cell Carcinoma-Analysis of Out Come Data of 100 Patients and Review of Literature.

Authors:  Jagdeesh Kulkarni; Yogesh Jadhav; Rohan S Valsangkar
Journal:  Indian J Surg Oncol       Date:  2011-12-20

8.  Surgical treatment of inferior vena cava tumor thrombus in patients with renal cell carcinoma.

Authors:  Tae-Won Kwon; Hyangkyoung Kim; Ki-Myung Moon; Yong-Pil Cho; Cheryn Song; Chung-Soo Kim; Hanjong Ahn
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

9.  Outcomes of renal cell carcinoma with associated venous tumor thrombus: experience from a large cohort and short time span in a single center.

Authors:  Zhigang Chen; Feilong Yang; Liyuan Ge; Min Qiu; Zhuo Liu; Cheng Liu; Xiaojun Tian; Shudong Zhang; Lulin Ma
Journal:  BMC Cancer       Date:  2021-07-02       Impact factor: 4.430

10.  Primary renal embryonal rhabdomyosarcoma in adults: a case report and review of the literature.

Authors:  Rafik Nabil Fanous; Erik K Mayer; Justin Vale; Josephine Lloyd; Marjorie M Walker
Journal:  Case Rep Oncol Med       Date:  2012-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.